The immunohistochemical investigations of cadherin “switch” during epithelial-mesenchymal transition of tongue squamous cell carcinoma

Romanian Journal of Morphology and Embryology

Volumn 55, Issue , 2014, Pages 1049-1056

  Afrem, Mihai Cătălin ^a   Mărgăritescu, Claudiu ^a   Crăiţoiu, Monica Mihaela ^a   Ciucă, Mirela ^a   Şarlă, Călin Gabriel ^b   Cotoi, Ovidiu Simion ^c  

^a UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

^b VASILE GOLDIS WESTERN UNIVERSITY OF ARAD   (Romania)

^c UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

E cadherin; Epithelial mesenchymal transition; N cadherin; Squamous cell carcinoma; Tongue; Vimentin

Indexed keywords

CADHERIN; VIMENTIN;

CELL DIFFERENTIATION; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TONGUE TUMOR;

CADHERINS; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; TONGUE NEOPLASMS; VIMENTIN;

EID: 84916217495     PISSN: 12200522     EISSN: 20668279     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Parkin DM, Bray F, Ferlay J, Pisani P, Global cancer statistics, 2002, CA Cancer J Clin, 2005, 55(2):74-108.
2. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D, Bray F, Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012, Eur J Cancer, 2013, 49(6):1374-1403.
3. Shiboski CH, Schmidt BL, Jordan RC, Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years, Cancer, 2005, 103(9):1843-1849.
4. Christiansen JJ, Rajasekaran AK, Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis, Cancer Res, 2006, 66(17):8319-8326.
5. Liang X, Zheng M, Jiang J, Zhu G, Yang J, Tang Y, Hypoxiainducible factor-1 alpha, in association with TWIST2 and SNIP1, is a critical prognostic factor in patients with tongue squamous cell carcinoma, Oral Oncol, 2011, 47(2):92-97.
6. Sakamoto K, Imanishi Y, Tomita T, Shimoda M, Kameyama K, Shibata K, Sakai N, Ozawa H, Shigetomi S, Fujii R, Fujii M, Ogawa K, Overexpression of SIP1 and downregulation of E-cadherin predict delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma after partial glossectomy, Ann Surg Oncol, 2011, 19(2):612-619.
7. Grille SJ, Bellacosa A, Upson J, Klein-Szanto AJ, van Roy F, Lee-Kwon W, Donowitz M, Tsichlis PN, Larue L, The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines, Cancer Res, 2003, 63(9):2172-2178.
8. Ikenouchi J, Matsuda M, Furuse M, Tsukita S, Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail, J Cell Sci, 2003, 116(Pt 10):1959-1967.
9. Thiery JP, Epithelial-mesenchymal transitions in tumour progression, Nat Rev Cancer, 2002, 2(6):442-454.
10. Takkunen M, Grenman R, Hukkanen M, Korhonen M, García de Herreros A, Virtanen I, Snail-dependent and-independent epithelial-mesenchymal transition in oral squamous carcinoma cells, J Histochem Cytochem, 2006, 54(11):1263-1275.
11. Acloque H, Thiery JP, Nieto MA, The physiology and pathology of the EMT. Meeting on the epithelial-mesenchymal transition, EMBO Rep, 2008, 9(4):322-326.
12. Kalluri R, Weinberg RA, The basics of epithelial-mesenchymal transition, J Clin Invest, 2009, 119(6):1420-1428.
13. Halbleib JM, Nelson WJ, Cadherins in development: cell adhesion, sorting, and tissue morphogenesis, Genes Dev, 2006, 20(33):3199-3214.
14. Liu LK, Jiang XY, Zhou XX, Wang DM, Song XL, Jiang HB, Upregulation of vimentin and aberrant expression of Ecadherin/beta-catenin complex in oral squamous cell carcinomas: correlation with the clinicopathological features and patient outcome, Mod Pathol, 2010, 23(2):213-224.
15. Wang X, Zhang J, Fan M, Zhou Q, Deng H, Aisharif MJ, Chen X, The expression of E-cadherin at the invasive tumor front of oral squamous cell carcinoma: immunohistochemical and RT-PCR analysis with clinicopathological correlation, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2009, 107(4):547-554.
16. Kosunen A, Pirinen R, Ropponen K, Pukkila M, Kellokoski J, Virtaniemi J, Sironen R, Juhola M, Kumpulainen E, Johansson R, Nuutinen J, Kosma VM, CD44 expression and its relationship with MMP-9, clinicopathological factors and survival in oral squamous cell carcinoma, Oral Oncol, 2007, 43(1):51-59.
17. Mattijssen V, Peters HM, Schalkwijk L, Manni JJ, van’t Hof-Grootenboer B, de Mulder PH, Ruiter DJ, E-cadherin expression in head and neck squamous-cell carcinoma is associated with clinical outcome, Int J Cancer, 1993, 55(4): 580-585.
18. Veness MJ, Tongue cancer in younger patients, Australas Radiol, 1999, 43(1):76-81.
19. Cruz MC, Pereira AL, Lopes FF, Nonaka CF, Silva RR, Freitas Rde A, Souza LB, Pinto LP, Immunohistochemical expression of E-cadherin and CD44v6 in squamous cell carcinomas of the lower lip and tongue, Braz Dent J, 2009, 20(1):64-69.
20. Diniz-Freitas M, García-Caballero T, Antúnez-López J, Gándara-Rey JM, García-García A, Reduced E-cadherin expression is an indicator of unfavourable prognosis in oral squamous cell carcinoma, Oral Oncol, 2006, 42(2):190-200.
21. Kawano T, Nakamura Y, Yanoma S, Kubota A, Furukawa M, Miyagi Y, Tsukuda M, Expression of E-cadherin, and CD44s and CD44v6 and its association with prognosis in head and neck cancer, Auris Nasus Larynx, 2004, 31(1):35-41.
22. Mahomed F, Altini M, Meer S, Altered E-cadherin/β-catenin expression in oral squamous carcinoma with and without nodal metastasis, Oral Dis, 2007, 13(4):386-392.
23. Hung KF, Chang CS, Liu CJ, Lui MT, Cheng CY, Kao SY, Differential expression of E-cadherin in metastatic lesions comparing to primary oral squamous cell carcinoma, J Oral Pathol Med, 2006, 35(10):589-594.
24. Lyakhovitsky A, Barzilai A, Fogel M, Trau H, Huszar M, Expression of E-cadherin and beta-catenin in cutaneous squamous cell carcinoma and its precursors, Am J Dermatopathol, 2004, 26(5):372-378.
25. Pyo SW, Hashimoto M, Kim YS, Kim CH, Lee SH, Johnson KR, Wheelock MJ, Park JU, Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: correlation with the clinicopathologic features and patient outcome, J Craniomaxillofac Surg, 2007, 35(1):1-9.
26. Zhong LP, Li J, Zhang CP, Zhu HG, Sun J, Zhang ZY, Expression of E-cadherin in cervical lymph nodes from primary oral squamous cell carcinoma patients, Arch Oral Biol, 2007, 52(8):740-747.
27. Wang X, Zhang J, Fan M, Zhou Q, Deng H, Aisharif MJ, Chen X, The expression of E-cadherin at the invasive tumor front of oral squamous cell carcinoma: immunohistochemical and RT-PCR analysis with clinicopathological correlation, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2009, 107(4):547-554.
28. Osborn M, Weber K, Tumor diagnosis by intermediate filament typing: a novel tool for surgical pathology, Lab Invest, 1983, 48(4):372-394.
29. Ramaekers F, Puts J, Kant A, Moesker O, Jap P, Vooijs P, Differential diagnosis of human carcinomas, sarcomas and their metastases using antibodies to intermediate-sized filaments, Eur J Cancer Clin Oncol, 1982, 18(12):1251-1257.
30. Paccione RJ, Miyazaki H, Patel V, Waseem A, Gutkind JS, Zehner ZE, Yeudall WA, Keratin down-regulation in vimentinpositive cancer cells is reversible by vimentin RNA interference, which inhibits growth and motility, Mol Cancer Ther, 2008, 7(9):2894-2903.
31. Mandal M, Myers JN, Lippman SM, Johnson FM, Williams MD, Rayala S, Ohshiro K, Rosenthal DI, Weber RS, Gallick GE, El-Naggar AK, Epithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor features, Cancer, 2008, 112(9):2088-2100.
32. de Araujo VC, Pinto Júnior DS, de Sousa SO, Nunes FD, de Araujo NS, Vimentin in oral squamous cell carcinoma, Eur Arch Otorhinolaryngol, 1993, 250(2):105-109.
33. Islam S, Kim JB, Trendel J, Wheelock MJ, Johnson KR, Vimentin expression in human squamous carcinoma cells: relationship with phenotypic changes and cadherin-based cell adhesion, J Cell Biochem, 2000, 78(1):141-150.
34. Nijkamp MM, Span PN, Hoogsteen IJ, van der Kogel AJ, Kaanders JH, Bussink J, Expression of E-cadherin and vimentin correlates with metastasis formation in head and neck squamous cell carcinoma patients, Radiother Oncol, 2011, 99(3):344-348.
35. Patel V, Hood BL, Molinolo AA, Lee NH, Conrads TP, Braisted JC, Krizman DB, Veenstra TD, Gutkind JS, Proteomic analysis of laser-captured paraffin-embedded tissues: a molecular portrait of head and neck cancer progression, Clin Cancer Res, 2008, 14(4):1002-1014.
36. Chaw SY, Majeed AA, Dalley AJ, Chan A, Stein S, Farah CS, Epithelial to mesenchymal transition (EMT) biomarkers-Ecadherin, beta-catenin, APC and Vimentin-in oral squamous cell carcinogenesis and transformation, Oral Oncol, 2012, 48(10):997-1006.
37. Bànkfalvi A, Piffkò J, Prognostic and predictive factors in oral cancer: the role of the invasive tumour front, J Oral Pathol Med, 2000, 29(7):291-298.
38. Gumbiner BM, Regulation of cadherin-mediated adhesion in morphogenesis, Nat Rev Mol Cell Biol, 2005, 6(8):622-634.
39. Hazan RB, Qiao R, Keren R, Badano I, Suyama K, Cadherin switch in tumor progression, Ann N Y Acad Sci, 2004, 1014:155-163.
40. Wheelock MJ, Johnson KR, Cadherins as modulators of cellular phenotype, Annu Rev Cell Dev Biol, 2003, 19:207-235.
41. Peralta Soler A, Knudsen KA, Jaurand MC, Johnson KR, Wheelock MJ, Klein-Szanto AJ, Salazar H, The differential expression of N-cadherin and E-cadherin distinguishes pleural mesotheliomas from lung adenocarcinomas, Hum Pathol, 1995, 26(12):1363-1369.
42. Islam S, Carey TE, Wolf GT, Wheelock MJ, Johnson KR, Expression of N-cadherin by human squamous carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell-cell adhesion, J Cell Biol, 1996, 135(6 Pt 1):1643-1654.
43. Kim JB, Islam S, Kim YJ, Prudoff RS, Sass KM, Wheelock MJ, Johnson KR, N-cadherin extracellular repeat 4 mediates epithelial to mesenchymal transition and increased motility, J Cell Biol, 2000, 151(6):1193-1206.
44. Nieman MT, Prudoff RS, Johnson KR, Wheelock MJ, N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression, J Cell Biol, 1999, 147(3):631-644.
45. Gravdal K, Halvorsen OJ, Haukaas SA, Akslen LA, A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer, Clin Cancer Res, 2007, 13(23):7003-7011.
46. Kim MA, Lee HS, Lee HE, Kim JH, Yang HK, Kim WH, Prognostic importance of epithelial-mesenchymal transitionrelated protein expression in gastric carcinoma, Histopathology, 2009, 54(4):442-451.
47. Matsunaga E, Suzuki K, Kato S, Kurotani T, Kobayashi K, Okanoya K, Dynamic expression of cadherins regulates vocal development in a songbird, PLoS One, 2011, 6(9): e25272.
48. Di Domenico M, Pierantoni GM, Feola A, Esposito F, Laino L, De Rosa A, Rullo R, Mazzotta M, Martano M, Sanguedolce F, Perillo L, D’Angelo L, Papagerakis S, Tortorella S, Bufo P, Lo Muzio L, Pannone G, Santoro A, Prognostic significance of N-cadherin expression in oral squamous cell carcinoma, Anticancer Res, 2011, 31(12):4211-4218.
49. Gasparotto D, Polesel J, Marzotto A, Colladel R, Piccinin S, Modena P, Grizzo A, Sulfaro S, Serraino D, Barzan L, Doglioni C, Maestro R, Overexpression of TWIST2 correlates with poor prognosis in head and neck squamous cell carcinomas, Oncotarget, 2011, 2(12):1165-1175.
50. Nguyen PT, Kudo Y, Yoshida M, Kamata N, Ogawa I, Takata T, N-cadherin expression is involved in malignant behavior of head and neck cancer in relation to epithelialmesenchymal transition, Histol Histopathol, 2011, 26(2):147-156.
51. Li S, Jiao J, Lu Z, Zhang M, An essential role for N-cadherin and beta-catenin for progression in tongue squamous cell carcinoma and their effect on invasion and metastasis of Tca8113 tongue cancer cells, Oncol Rep, 2009, 21(5):1223-1233.
52. Hashimoto T, Soeno Y, Maeda G, Taya Y, Aoba T, Nasu M, Kawashiri S, Imai K, Progression of oral squamous cell carcinoma accompanied with reduced E-cadherin expression but not cadherin switch, PLoS One, 2012, 7(10):e47899.